logo
Here are Monday's biggest analyst calls: Apple, Tesla, Amazon, Nike, Microsoft, Walmart & more

Here are Monday's biggest analyst calls: Apple, Tesla, Amazon, Nike, Microsoft, Walmart & more

CNBC20 hours ago
Here are the biggest calls on Wall Street on Monday: JPMorgan upgrades Mara to overweight from neutral JPMorgan says it sees upside for the bitcoin miner. "We are upgrading MARA to OW (from Neutral), as shares do not reflect the company's revised YE25 hashrate target, even after considering capex requirements." Morgan Stanley reiterates Amazon as overweight Morgan Stanley says Amazon is a beneficiary of the Big Beautiful bill passed by Congress. "We see AMZN capturing ~$15bn/year in tax benefits. While most will be re-invested in AWS, even investing 50% of the annual cash flow benefit paints a much faster path to billions of annual automation savings." Wells Fargo initiates Take-Two Interactive as overweight Wells says it's bullish on the release of Grand Theft Auto in 2026 for Take-Two . "We anticipate GTA 6 sells 50M units in FY27, the first year post-launch, at an $80 base game retail ASP [average selling price]." BMO initiates MongoDB as outperform BMO says it likes the cloud database company's valuation. "We are launching on MongoDB with an Outperform rating and a $280 target price." Bank of America reiterates Apple as buy Bank of America says all "eyes [are] on margins" ahead of Apple earnings later this week. "As we head into F3Q25 (June qtr) earnings aftermarket on Thur July 31, we see client sentiment as fairly negative given uncertain impact from tariffs, U.S. DOJ investigation (Google TAC payments), App Store headwinds, and slow progress in AI." Mizuho downgrades GE Vernova to neutral from outperform The firm increased its price target but downgraded GE Vernova on valuation. "We increase our PT to $670, up 63%, due to accelerating EBITDA margins in power and electrification business and higher gas power manufacturing capacity beyond 2028" Morgan Stanley upgrades Hesai to overweight from equal weight Morgan Stanley says it's bullish on shares of the autonomous driving company. "We expect robotaxis and smart home robotic appliances to serve as Hesai's second revenue growth driver from 2026 onwards." Bernstein upgrades Charter to outperform from market perform Bernstein says investors should buy the dip in the cable giant. "For CHTR, it's the secular challenges that seem to stretch further with each earnings call, and this one certainly didn't help. But as we reflect in the summer heat on what's shaping up to be a tough 2H, we are looking ahead to CHTR's narrative for '26. July is nearly behind us, and this unusual heat, too, will pass." Read more. Deutsche Bank reiterates Tesla as buy Deutsche says more "patience" is needed for Tesla's robotaxi service but that it's sticking with the stock. " Tesla's robotaxi service is currently still very small scale, having accumulated only +7k miles since the launch on June 22nd with 10-20 vehicles in the fleet. Management did not provide a lot of clarity regarding the pace of expansion although Elon Musk indicated the goal of technically being able to cover half the US population by year-end." Oppenheimer initiates Wave Life Sciences as outperform Oppenheimer says shares of the biotech company have plenty room to run. "We initiate Wave Life Sciences (WVE) with an Outperform rating and a $24 price target." Canaccord initiates Gold Fields as buy Canaccord says the gold company is well positioned. " Gold Fields (GFI) is one of the top 10 gold producers globally with 10 operations and is headquartered in South Africa." Morgan Stanley reiterates Walmart as overweight Morgan Stanley says Walmart is a "clear leader" in retail AI. "AI use cases in Food Retail are accelerating, driving stronger sales growth and greater efficiencies. WMT a clear leader." Evercore ISI downgrades Cisco to in line from outperform Evercore downgraded the stock mainly on valuation. "We are downgrading Cisco to In Line as the stock is within 6% of our price target of $72. The stock has performed well recently with a +46% move over the last twelve months vs. +17% for the S & P." Bank of America reinstates Surgery Partners as buy The firm moved to buy from no rating on the outpatient surgery company and says the stock is being unfairly punished. "We change our rating on SRGY to Buy from No Rating as we no longer believe that the stock is trading on deal speculation (on 6/17, SGRY rejected the buyout offer from Bain Capital)." Wolfe upgrades Texas Instruments to outperform from neutral Wolfe says it likes the company's multi-year CapEx Plan. "We're upgrading TXN from Peer Perform to Outperform and setting a $230 price target." JPMorgan upgrades Nike to overweight from equal weight The firm says the turnaround is underway at Nike. "NKE is the global athletic market leader with diversification across product categories, geographies, and distribution, and we see the model at an inflection for revenue growth to re-accelerate into 2H26/FY27 following several quarters of franchise product lifecycle management & inventory liquidation headwinds." Read more. Benchmark initiates Lionsgate Studios as buy The firm says it's bullish on shares of the movie studio company. "We are initiating coverage of Lionsgate Studios with a BUY rating and an $8.50 eighteen-month price target." Stifel reiterates Microsoft as buy Stifel raised its price target on Microsoft to $550 per share from $500 ahead of earnings later this week. "Looking forward, we believe management's prior expectation that supply/demand imbalances would linger beyond June will be further pushed out to F2H26, and we also expect FY26 capex commentary could likely exceed our./street estimates of ~$110B/$100B, respectively, echoing Alphabet's commentary during earnings." JPMorgan downgrades American Eagle to underweight from neutral The firm says the lifestyle retailer is is showing signs of a "promotional overhang." "Conversely, we downgrade AEO to Underweight - modeling 2Q SSS/EPS more/less in-line with guidance/Street flagging our 3Q25 EPS 12% below Consensus on elevated advertising investments Y/Y and potential promotional 'overhang' post 1H merchandising mis-execution with our FY26 EPS 15% below the Street." Read more. Argus upgrades Las Vegas Sands to buy from neutral Argus says it's like Las Vegas Sands capital investments. "We expect the shares to rally now that the company has completed its capital investment programs."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘It's Only Just Begun,' Says Andres Sheppard About Tesla Stock
‘It's Only Just Begun,' Says Andres Sheppard About Tesla Stock

Business Insider

time27 minutes ago

  • Business Insider

‘It's Only Just Begun,' Says Andres Sheppard About Tesla Stock

Tesla (NASDAQ:TSLA) stock is steering into the future – quite literally. On June 22, the company officially launched its much-anticipated robotaxi service in Austin. Tesla began using Model Y vehicles equipped with autonomous driving technology to transport select invite-only passengers around predefined neighborhoods at a playful flat fee of $4.20 per ride. For now, however, each vehicle still includes a safety monitor seated in the front passenger seat, providing an additional layer of supervision and reassurance during these autonomous trips. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. It wasn't long before Tesla took its next leap forward: on June 27, the company completed its first fully autonomous vehicle delivery. Imagine a Model Y quietly departing Tesla's Gigafactory, cruising effortlessly through Austin's streets, and parking itself in the customer's driveway without a single human intervention – that's exactly what happened. Furthermore, the company announced plans last week to ramp up its robotaxi operation in Austin by adding more vehicles and expanding service coverage. As the system matures and local regulations allow, Tesla aims to phase out the in-car safety monitors altogether, ushering in a truly driverless passenger experience. Looking further ahead, Tesla is already sketching out the next generation of autonomous ride-sharing. In 2026, the automaker plans to roll out its futuristic Cybercab – a purpose-built, fully autonomous vehicle without a steering wheel or pedals. Cantor analyst Andres Sheppard sees Tesla's latest moves as another powerful signal of the company's strategic edge in the rapidly evolving autonomous vehicle landscape. According to Sheppard, Tesla's focus on expanding its robotaxi services marks a critical step toward solidifying its role as a frontrunner in the competitive ride-sharing market. 'We expect Robotaxi expansion into the Bay Area (in 3Q), followed by Arizona, Nevada and possibly Florida (in 4Q25/2026E), subject to regulatory approvals… Overall, we continue to see Tesla's Robotaxi segment as a software-as-a-service, high-margin model, and we expect TSLA to have the ability to rapidly scale following commercialization. We expect TSLA will capture a leading market share in these industries,' Sheppard opined. To this end, Sheppard rates TSLA shares an Overweight (i.e., Buy) along with a $355 price target. (To watch Sheppard's track record, click here) What does the rest of the Street think? Looking at the consensus breakdown, opinions from other analysts are more spread out. 14 Buys, 15 Holds and 8 Sells add up to a Hold (i.e. Neutral) consensus rating. In addition, the $310.65 average price target indicates ~5% downside from current levels. (See TSLA stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.

Tesla Faces $5,900 Robot Challenger as Unitree Unveils R1 Humanoid
Tesla Faces $5,900 Robot Challenger as Unitree Unveils R1 Humanoid

Business Insider

time27 minutes ago

  • Business Insider

Tesla Faces $5,900 Robot Challenger as Unitree Unveils R1 Humanoid

Chinese robotics company Unitree has revealed its new humanoid robot, the R1, with a starting price of $5,900. The company introduced the robot at the World AI Conference in Shanghai last week. The R1 drew public attention for its agility, including cartwheels and balance moves, demonstrated in live videos and online clips. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The R1 stands 4 feet tall and weighs 55 pounds. It includes 26 joints for multi-axis mobility and features voice and image recognition tools. Unitree states that the robot utilizes an 8-core chip with an integrated GPU. The device supports Wi-Fi 6 and Bluetooth 5.2 and includes a removable battery with a runtime of around one hour. The launch adds pressure to other companies in the humanoid robotics space, including Tesla (TSLA). Tesla has yet to ship its Optimus robot and has not confirmed a production date, although Elon Musk projects producing 100,000 robots every month by 2030. Musk has also estimated that Optimus will cost at least $20,000. That is more than three times the R1's announced price. The R1's hardware shows a focus on motion over task performance. It does not include usable hands or physical manipulation tools. Analysts note that it is designed for testing and software development, rather than for home or factory use. Unitree has not provided a delivery timeline, but states that the robot is still in development. The company expects to use third-party dealers for global distribution. Previous Unitree robots have carried higher price tags. The G1 humanoid started at $16,000, while the H1 model reached a price of $90,000. The company says it wants to lower cost barriers for developers and early adopters. A Growing Industry The humanoid robotics space has drawn rising interest from investors. Boston Dynamics, owned by Hyundai Motor Company (HYMLF), has developed its Atlas robot for research use, but its price exceeds $100,000. Other companies working in the field include Agility Robotics, Apptronik, and Sanctuary AI, all of which are focused on enterprise deployment. The R1 launch aligns with government targets in China, where robotics is a national priority under industrial policy plans. Unitree has stated that it aims to integrate humanoid robots into homes and offices in the long term. For now, the R1 adds a new price benchmark in a market still early in commercial adoption. We used TipRanks' Comparison Tool to analyze Hyundai Motor Company (HYMLF) and Tesla (TSLA), both mentioned in the article. This gives you a broader view of how the two stocks compare across key metrics.

What's Ahead for UnitedHealth (UNH) as Stock Drops 44% YTD?
What's Ahead for UnitedHealth (UNH) as Stock Drops 44% YTD?

Business Insider

time27 minutes ago

  • Business Insider

What's Ahead for UnitedHealth (UNH) as Stock Drops 44% YTD?

UnitedHealth Group (UNH), the largest healthcare provider, is now one of the worst-hit stocks of 2025. Down 44% year-to-date, UNH stock was dragged down by rising costs in its Medicare Advantage business, a surprise CEO exit, and intensifying federal scrutiny into its billing practices. Currently, investors are looking for updates on the company's progress on the legal and financial front at the Q2 earnings, due July 29. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. What Went Wrong? The selloff in UNH stock began in April when UnitedHealth missed earnings and slashed its full-year guidance. This was followed by the resignation of CEO Andrew Witty in May. Also, last week, the company confirmed it is under both criminal and civil investigations by the Department of Justice. The probe centers on alleged overbilling in its Medicare Advantage program, specifically whether patient diagnoses were inflated to boost government reimbursements. Analysts Are Not That Bearish Despite the turmoil, Wall Street sentiment is mixed but not entirely bearish. Bernstein even named UNH a 'Top Pick,' citing its discounted valuation and long-term earnings potential. Further, the firm expects a doubling of EPS by 2029, driven by sector recovery and company-specific margin recovery. Others are more cautious. Wells Fargo and Truist Financial recently lowered their price targets, citing weak investor sentiment and concerns around Optum Health, UnitedHealth's services arm. All Eyes Are on UNH's Q2 Results Currently, analysts anticipate that Q2 earnings will fall to $4.48 from $6.80 a year ago. Meanwhile, revenue is expected to grow 12.8% to $111.50 billion. The bottom-line drop reflects higher-than-expected medical costs, especially in Medicare Advantage, which have hurt the company's margins. More than the Q2 numbers, investors are focused on CEO Stephen Hemsley offering a roadmap for recovery, including updated 2025 guidance and early signals for 2026. A full-year EPS outlook of below $18 could result in investors losing more confidence and trigger further selling. Is UNH a Good Buy Right Now? Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, five Holds, and one Sell assigned in the last three months. At $348.12, the average UnitedHealth stock price target implies a 24.11% upside potential.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store